TY - JOUR
T1 - Guidance for substantiating the evidence for beneficial effects of probiotics
T2 - Current status and recommendations for future research
AU - Rijkers, Ger T.
AU - Bengmark, Stig
AU - Enck, Paul
AU - Haller, Dirk
AU - Herz, Udo
AU - Kalliomaki, Marko
AU - Kudo, Satoshi
AU - Lenoir-Wijnkoop, Irene
AU - Mercenier, Annick
AU - Myllyluoma, Eveliina
AU - Rabot, Sylvie
AU - Rafter, Joseph
AU - Szajewska, Hania
AU - Watzl, Bernhard
AU - Wells, Jerry
AU - Wolvers, Danielle
AU - Antoine, Jean Michel
PY - 2010/3
Y1 - 2010/3
N2 - Probiotic bacteria are live microorganisms that, when administered in adequate amounts, confer a health benefit on the host. There is a growing interest in probiotics within the scientific community, with consumers, and in the food industry. The interactions between the gut and intestinal microbiota and between resident and transient microbiota define a new arena in physiology, an understanding of which would shed light on the "cross-talk" between humans and microbes. The different beneficial effects of specific probiotic strains may be translated into different health claims. However, there is a need for comprehensive and harmonized guidelines on the assessment of the characteristics and efficacy of probiotics and of foods containing them. An international expert group of ILSI has evaluated the published evidence of the functionality of different probiotics in 4 areas of (human) application: 1) metabolism, 2) chronic intestinal inflammatory and functional disorders, 3) infections, and 4) allergy. Based on the existing evidence, concrete examples of demonstration of benefits and gaps are listed, and guidelines and recommendations are defined that should help design the next generation of probiotic studies.
AB - Probiotic bacteria are live microorganisms that, when administered in adequate amounts, confer a health benefit on the host. There is a growing interest in probiotics within the scientific community, with consumers, and in the food industry. The interactions between the gut and intestinal microbiota and between resident and transient microbiota define a new arena in physiology, an understanding of which would shed light on the "cross-talk" between humans and microbes. The different beneficial effects of specific probiotic strains may be translated into different health claims. However, there is a need for comprehensive and harmonized guidelines on the assessment of the characteristics and efficacy of probiotics and of foods containing them. An international expert group of ILSI has evaluated the published evidence of the functionality of different probiotics in 4 areas of (human) application: 1) metabolism, 2) chronic intestinal inflammatory and functional disorders, 3) infections, and 4) allergy. Based on the existing evidence, concrete examples of demonstration of benefits and gaps are listed, and guidelines and recommendations are defined that should help design the next generation of probiotic studies.
UR - http://www.scopus.com/inward/record.url?scp=77249119242&partnerID=8YFLogxK
U2 - 10.3945/jn.109.113779
DO - 10.3945/jn.109.113779
M3 - Article
C2 - 20130080
AN - SCOPUS:77249119242
SN - 0022-3166
VL - 140
SP - 671S-676S
JO - Journal of Nutrition
JF - Journal of Nutrition
IS - 3
ER -